换一批
换一批Lenvatinib, an oral multi-kinases inhibitor, -associated hypertension: Potential role of vascular endothelial dysfunction.
作者：
主题词
投药, 口服(Administration, Oral);老年人(Aged);老年人, 80以上(Aged, 80 and over);血压(Blood Pressure);血压测定(Blood Pressure Determination);疾病恶化(Disease Progression);剂量效应关系, 药物(Dose-Response Relationship, Drug);内皮, 血管(Endothelium, Vascular);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);高血压(Hypertension);发病率(Incidence);日本(Japan);男(雄)性(Male);中年人(Middle Aged);一氧化氮(Nitric Oxide);苯脲化合物(Phenylurea Compounds);预后(Prognosis);前瞻性研究(Prospective Studies);蛋白激酶抑制剂(Protein Kinase Inhibitors);喹啉类(Quinolines);危险因素(Risk Factors);甲状腺肿瘤(Thyroid Neoplasms);血管内皮生长因子A(Vascular Endothelial Growth Factor A);血管阻力(Vascular Resistance)
DOI
10.1016/j.atherosclerosis.2017.03.039
PMID
28390289
发布时间
2018-05-18
- 浏览0
Atherosclerosis
116-120页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
